331 related articles for article (PubMed ID: 21358653)
1. Focal segmental glomerulosclerosis in IgA nephropathy: a result of primary podocyte injury?
Cook HT
Kidney Int; 2011 Mar; 79(6):581-583. PubMed ID: 21358653
[TBL] [Abstract][Full Text] [Related]
2. Focal segmental glomerulosclerosis plays a major role in the progression of IgA nephropathy. I. Immunohistochemical studies.
Hill GS; Karoui KE; Karras A; Mandet C; Van Huyen JD; Nochy D; Bruneval P
Kidney Int; 2011 Mar; 79(6):635-642. PubMed ID: 21160460
[TBL] [Abstract][Full Text] [Related]
3. Focal segmental glomerulosclerosis plays a major role in the progression of IgA nephropathy. II. Light microscopic and clinical studies.
El Karoui K; Hill GS; Karras A; Moulonguet L; Caudwell V; Loupy A; Bruneval P; Jacquot C; Nochy D
Kidney Int; 2011 Mar; 79(6):643-654. PubMed ID: 21178978
[TBL] [Abstract][Full Text] [Related]
4. Evidence from the Oxford Classification cohort supports the clinical value of subclassification of focal segmental glomerulosclerosis in IgA nephropathy.
Bellur SS; Lepeytre F; Vorobyeva O; Troyanov S; Cook HT; Roberts IS;
Kidney Int; 2017 Jan; 91(1):235-243. PubMed ID: 27914703
[TBL] [Abstract][Full Text] [Related]
5. Evidence from the large VALIGA cohort validates the subclassification of focal segmental glomerulosclerosis in IgA nephropathy.
Bellur SS; Troyanov S; Vorobyeva O; Coppo R; Roberts ISD;
Kidney Int; 2024 Jun; 105(6):1279-1290. PubMed ID: 38554992
[TBL] [Abstract][Full Text] [Related]
6. Oxford Classification of IgA nephropathy 2016: an update from the IgA Nephropathy Classification Working Group.
Trimarchi H; Barratt J; Cattran DC; Cook HT; Coppo R; Haas M; Liu ZH; Roberts IS; Yuzawa Y; Zhang H; Feehally J; ;
Kidney Int; 2017 May; 91(5):1014-1021. PubMed ID: 28341274
[TBL] [Abstract][Full Text] [Related]
7. Podocyte injury as a potential therapeutic target in IgA nephropathy: should pathology guide us?
Haas M
Kidney Int; 2024 Jun; 105(6):1165-1167. PubMed ID: 38777401
[TBL] [Abstract][Full Text] [Related]
8. Expression of DENDRIN in several glomerular diseases and correlation to pathological parameters and renal failure - preliminary study.
Mizdrak M; Vukojević K; Filipović N; Čapkun V; Benzon B; Durdov MG
Diagn Pathol; 2018 Nov; 13(1):90. PubMed ID: 30458823
[TBL] [Abstract][Full Text] [Related]
9. [Pathogenic Mechanisms of the Focal Segmental Glomerulosclerosis and Its Role in the Progression of IgA Nephropathy].
Chen ZJ; Li C; Li H; Li XW
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2018 Aug; 40(4):549-555. PubMed ID: 30193611
[TBL] [Abstract][Full Text] [Related]
10. Is it possible to predict parameters of the Oxford classification of primary IgA Nephropathy from clinical laboratory data? Focus on the role of segmental glomerulosclerosis subtypes.
Monteiro MLGDR; Vieira MR; Pereira LHM; Araújo LS; Silva CA; Araújo LB; Rocha LP; Reis MAD; Machado JR
Pathol Res Pract; 2019 Oct; 215(10):152533. PubMed ID: 31320251
[TBL] [Abstract][Full Text] [Related]
11. The implications of focal segmental glomerulosclerosis in children with IgA nephropathy.
Trimarchi H; Coppo R
Pediatr Nephrol; 2020 Nov; 35(11):2043-2047. PubMed ID: 31773265
[TBL] [Abstract][Full Text] [Related]
12. Immunoglobulin a nephropathy: Pathological markers of renal survival in paediatric patients.
Fabiano RC; Pinheiro SV; de Almeida Araújo S; Simões E Silva AC
Nephrology (Carlton); 2016 Dec; 21(12):995-1002. PubMed ID: 27414046
[TBL] [Abstract][Full Text] [Related]
13. Focal segmental glomerulosclerosis: cellular variant and beyond.
Nair R
Kidney Int; 2006 Nov; 70(10):1676-8. PubMed ID: 17080157
[TBL] [Abstract][Full Text] [Related]
14. IgA nephropathy histologically resembling focal-segmental glomerulosclerosis: a clinicopathologic study of 18 cases.
Haas M
Am J Kidney Dis; 1996 Sep; 28(3):365-71. PubMed ID: 8804234
[TBL] [Abstract][Full Text] [Related]
15. A histologic classification of IgA nephropathy for predicting long-term prognosis: emphasis on end-stage renal disease.
Kawamura T; Joh K; Okonogi H; Koike K; Utsunomiya Y; Miyazaki Y; Matsushima M; Yoshimura M; Horikoshi S; Suzuki Y; Furusu A; Yasuda T; Shirai S; Shibata T; Endoh M; Hattori M; Katafuchi R; Hashiguchi A; Kimura K; Matsuo S; Tomino Y;
J Nephrol; 2013; 26(2):350-7. PubMed ID: 22684645
[TBL] [Abstract][Full Text] [Related]
16. Focal segmental glomerulosclerosis in mild IgA nephropathy: a clinical-pathologic study.
Weber CL; Rose CL; Magil AB
Nephrol Dial Transplant; 2009 Feb; 24(2):483-8. PubMed ID: 18786972
[TBL] [Abstract][Full Text] [Related]
17. FSGS lesions in IgA nephropathy.
Fogo AB; Alpers CE; D'Agati VD
Kidney Int; 2011 Aug; 80(3):319; author reply 319-20. PubMed ID: 21760605
[No Abstract] [Full Text] [Related]
18. α-1-Antitrypsin detected by MALDI imaging in the study of glomerulonephritis: Its relevance in chronic kidney disease progression.
Smith A; L'Imperio V; De Sio G; Ferrario F; Scalia C; Dell'Antonio G; Pieruzzi F; Pontillo C; Filip S; Markoska K; Granata A; Spasovski G; Jankowski J; Capasso G; Pagni F; Magni F
Proteomics; 2016 Jun; 16(11-12):1759-66. PubMed ID: 26749278
[TBL] [Abstract][Full Text] [Related]
19. Focal and segmental glomerulosclerosis in murine models: a histological and ultrastructural characterization with immunohistochemistry correlation of glomerular CD44 and WT1 expression.
Husain S; Ginawi I; Bashir AI; Kfoury H; Al Johani TE; Hagar H; Raddaoui L; Al Ghonaim M; Alsuwaida A
Ultrastruct Pathol; 2018; 42(5):430-439. PubMed ID: 30285525
[TBL] [Abstract][Full Text] [Related]
20. Comprehensive evaluation of the significance of immunofluorescent findings on clinicopathological features in IgA nephropathy.
Katafuchi R; Nagae H; Masutani K; Tsuruya K; Mitsuiki K
Clin Exp Nephrol; 2019 Feb; 23(2):169-181. PubMed ID: 30066158
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]